-
A case of fatal respiratory diphtheria in an unvaccinated Pennsylvania resident who had visited Haiti brings to light the need for all international travelers to be current with all recommended vaccinations, including a primary series of diphtheria toxoid.
-
The NIH has halted the estrogen-alone wing of the Womens Health Initiative a year before its scheduled end.
-
-
-
The emergency contraceptive (EC) Plan B may be available over the counter (OTC) to women ages 16 and older if the Food and Drug Administration (FDA) approves Pomona, NY-based Barr Pharmaceuticals revised request for OTC status.
-
Two potential candidates in the microbicide research pipeline are set to be examined in clinical trials this fall, with research to focus on the safety and acceptability in healthy women and women infected with HIV.
-
Your next patient is a 17-year-old female who is interested in contraception. While she says she knows about the contraceptive patch and the vaginal ring, when you ask her about their effectiveness in preventing sexually transmitted diseases (STDs), she gives you a puzzled look.
-
As the number of international research protocols increase, the problems faced by reviewing IRBs increase. International research is taking more and more IRB time, says Howard Guenther, PhD, MBA, associate vice chancellor for research and interim executive secretary of the Institutional Review Board at the University of Illinois at Urbana-Champaign.
-
-
A new study from researchers at the Dana-Farber Cancer Institute in Boston indicates that a long-held belief among oncologists that patients who participate in clinical trials have better outcomes overall than those who do not may not be supported by empirical evidence.
